Literature DB >> 3223939

Improved procedure for the construction of neoglycolipids having antigenic and lectin-binding activities, from reducing oligosaccharides.

M S Stoll1, T Mizuochi, R A Childs, T Feizi.   

Abstract

Conditions have been established for the rapid and efficient conjugation of reducing oligosaccharides (di- to deca-saccharides) to dipalmitoyl phosphatidylethanolamine. The resulting neoglycolipids derived from several naturally occurring oligosaccharides and a series of N-linked high-mannose-type oligosaccharides released by hydrazinolysis from RNAase B showed specific and potent reactivities, as appropriate, with monoclonal antibodies to blood group Lewis(b), blood group A or a stage-specific embryonic (SSEA-1) antigen, or the lectin concanavalin A.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3223939      PMCID： PMC1135460          DOI： 10.1042/bj2560661

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


  15 in total

1.  Some nitrogen-containing disaccharides isolated from human blood-group A substance.

Authors:  R H COTE; W T MORGAN
Journal:  Nature       Date:  1956-11-24       Impact factor: 49.962

2.  Differing reactions of monoclonal anti-A antibodies with oligosaccharides related to blood group A.

Authors:  H C Gooi; E F Hounsell; J K Picard; A D Lowe; D Voak; E S Lennox; T Feizi
Journal:  J Biol Chem       Date:  1985-10-25       Impact factor: 5.157

3.  Antibodies against cell surface carbohydrates: determination of antigen structure.

Authors:  J L Magnani; S L Spitalnik; V Ginsburg
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: chemical basis of qualitative A1 and A2 distinction.

Authors:  H Clausen; S B Levery; E Nudelman; S Tsuchiya; S Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

5.  The use of reductaminated sugars for the preparation of oligosaccharide conjugates, I. Synthetic glycolipids containing glycosphingolipid-derived oligosaccharides.

Authors:  H Wiegandt; W Ziegler
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1974-01

6.  [Demonstration of oligosaccharidosuria associated with various meliturias, and determination of the structure of the oligosaccharides excreted. Hypothesis concerning the origins of oligosaccharides in biological fluids].

Authors:  G Strecker; C Trentesaux-Chauvet; T Riazi-Farzad; B Fournet; S Bouquelet; J Montreuil
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1973-10-15

7.  Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1).

Authors:  D Solter; B B Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

8.  Fractionation of glycopeptides by affinity column chromatography on concanavalin A-sepharose.

Authors:  S Ogata; T Muramatsu; A Kobata
Journal:  J Biochem       Date:  1975-10       Impact factor: 3.387

9.  Novel approach to the study of the antigenicities and receptor functions of carbohydrate chains of glycoproteins.

Authors:  P W Tang; H C Gool; M Hardy; Y C Lee; T Feizi
Journal:  Biochem Biophys Res Commun       Date:  1985-10-30       Impact factor: 3.575

10.  Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors.

Authors:  J Hilkens; F Buijs; J Hilgers; P Hageman; J Calafat; A Sonnenberg; M van der Valk
Journal:  Int J Cancer       Date:  1984-08-15       Impact factor: 7.396
View more
  19 in total

1.  Neoglycolipids as probes of oligosaccharide recognition by recombinant and natural mannose-binding proteins of the rat and man.

Authors:  R A Childs; K Drickamer; T Kawasaki; S Thiel; T Mizuochi; T Feizi
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

2.  Determination of structural elements of the L2/HNK-1 carbohydrate epitope required for its function.

Authors:  B Schmitz; M Schachner; Y Ito; T Nakano; T Ogawa
Journal:  Glycoconj J       Date:  1994-08       Impact factor: 2.916

3.  Immunoreactivity of neoglycolipids constructed from oligomannosidic residues of the Candida albicans cell wall.

Authors:  C Faille; J C Michalski; G Strecker; D W Mackenzie; D Camus; D Poulain
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

4.  The preparation of neoglycoconjugates containing inter-saccharide phosphodiester linkages as potential anti-Leishmania vaccines.

Authors:  F H Routier; A V Nikolaev; M A Ferguson
Journal:  Glycoconj J       Date:  1999-12       Impact factor: 2.916

5.  Monoclonal antibodies VIB-E3, IB5 and HB9 to the leucocyte/epithelial antigen CD24 resemble BA-1 in recognizing sialic acid-dependent epitope(s). Evidence that VIB-E3 recognizes NeuAc alpha 2-6GalNAc and NeuAc alpha 2-6Gal sequences.

Authors:  M Larkin; W Knapp; M S Stoll; H Mehmet; T Feizi
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

6.  Progress in deciphering the information content of the 'glycome'--a crescendo in the closing years of the millennium.

Authors:  T Feizi
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

7.  Different sialyltransferase activities in human colorectal carcinoma cells from surgical specimens detected by specific glycoprotein and glycolipid acceptors.

Authors:  W Kemmner; D Krück; P Schlag
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

8.  Chitovibrin: a chitin-binding lectin from Vibrio parahemolyticus.

Authors:  O S Gildemeister; B C Zhu; R A Laine
Journal:  Glycoconj J       Date:  1994-12       Impact factor: 2.916

9.  Membrane microdomains from early gastrula embryos of medaka, Oryzias latipes, are a platform of E-cadherin- and carbohydrate-mediated cell-cell interactions during epiboly.

Authors:  Tomoko Adachi; Chihiro Sato; Yasunori Kishi; Kazuhide Totani; Takeomi Murata; Taichi Usui; Ken Kitajima
Journal:  Glycoconj J       Date:  2008-09-03       Impact factor: 2.916

10.  Differences in the binding specificities of Pseudomonas aeruginosa M35 and Escherichia coli C600 for lipid-linked oligosaccharides with lactose-related core regions.

Authors:  I J Rosenstein; C T Yuen; M S Stoll; T Feizi
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.